Jasper Therapeutics, Inc.
USD0.01
+0.00 (+16.38%)
CEO
Jeet Mahal
IPO Date
2026-03-06
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$0.08
Prev. Close
$0.01
Day Low
$0.01
Day High
$0.08
52W Low
$0.01
52W High
$0.08
Market Cap
$0.00B
Volume
0.03M
| 10,000 |
| $0.64 |
| 20 Nov 2023 | WIGGANS THOMAS G | director | P-Purchase | Acquired | 10,000 | $0.63 |
| 20 Nov 2023 | WIGGANS THOMAS G | director | P-Purchase | Acquired | 10,000 | $0.60 |
| 20 Nov 2023 | WIGGANS THOMAS G | director | P-Purchase | Acquired | 10,000 | $0.60 |
| 2 Nov 2023 | WIGGANS THOMAS G | director | A-Award | Acquired | 110,000 | $0.69 |
| 2 Nov 2023 | WIGGANS THOMAS G | director: | Disposed | 0 | $0.00 |
| 13 Oct 2023 | Lis William | director | S-Sale | Disposed | 7,965 | $0.85 |
| 13 Oct 2023 | MARTELL RON | director, officer: President, CEO & Director | F-InKind | Disposed | 87,531 | $0.85 |
| 26 Sept 2023 | CROSS HERB | Chief Financial Officer | A-Award | Acquired | 550,000 | $0.78 |